Gibson GE - Search Results

1

Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.

Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, Bettendorff L, Chen Z, Flowers SA, Gerber LM, Grandville T, Schupf N, Xu H, Stern Y, Habeck C, Jordan B, Fonzetti P. Gibson GE, et al. J Alzheimers Dis. 2020;78(3):989-1010. doi: 10.3233/JAD-200896. J Alzheimers Dis. 2020. PMID: 33074237 Free PMC article. Clinical Trial.

2

Nonneural markers in Alzheimer disease.

Blass JP, Gibson GE. Blass JP, et al. Among authors: gibson ge. Alzheimer Dis Assoc Disord. 1992 Winter;6(4):205-24. doi: 10.1097/00002093-199206040-00003. Alzheimer Dis Assoc Disord. 1992. PMID: 1290624 Review.

3

Selective alteration of neurotransmitter release by low oxygen in vitro.

Hirsch JA, Gibson GE. Hirsch JA, et al. Among authors: gibson ge. Neurochem Res. 1984 Aug;9(8):1039-49. doi: 10.1007/BF00964800. Neurochem Res. 1984. PMID: 6149480

4

Thiamin antagonists and the release of acetylcholine and norepinephrine from brain slices.

Hirsch JA, Gibson GE. Hirsch JA, et al. Among authors: gibson ge. Biochem Pharmacol. 1984 Jul 15;33(14):2325-7. doi: 10.1016/0006-2952(84)90673-7. Biochem Pharmacol. 1984. PMID: 6466354 No abstract available.

5

Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy.

Park LC, Albers DS, Xu H, Lindsay JG, Beal MF, Gibson GE. Park LC, et al. Among authors: gibson ge. J Neurosci Res. 2001 Dec 1;66(5):1028-34. doi: 10.1002/jnr.10062. J Neurosci Res. 2001. PMID: 11746433

6

Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme.

Gibson GE, Zhang H, Xu H, Park LC, Jeitner TM. Gibson GE, et al. Biochim Biophys Acta. 2002 Mar 16;1586(2):177-89. doi: 10.1016/s0925-4439(01)00091-6. Biochim Biophys Acta. 2002. PMID: 11959459 Free article.

7

Abnormalities in oxidative processes in non-neuronal tissues from patients with Alzheimer's disease.

Gibson GE, Zhang H. Gibson GE, et al. J Alzheimers Dis. 2001 Jun;3(3):329-338. doi: 10.3233/jad-2001-3308. J Alzheimers Dis. 2001. PMID: 12214054

8

The role of the metabolic lesion in Alzheimer's disease.

Blass JP, Gibson GE, Hoyer S. Blass JP, et al. Among authors: gibson ge. J Alzheimers Dis. 2002 Jun;4(3):225-32. doi: 10.3233/jad-2002-4312. J Alzheimers Dis. 2002. PMID: 12226541 Review.

9

Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation.

Huang HM, Zhang H, Xu H, Gibson GE. Huang HM, et al. Among authors: gibson ge. Biochim Biophys Acta. 2003 Jan 20;1637(1):119-26. doi: 10.1016/s0925-4439(02)00222-3. Biochim Biophys Acta. 2003. PMID: 12527416 Free article.

10

Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death.

Huang HM, Ou HC, Xu H, Chen HL, Fowler C, Gibson GE. Huang HM, et al. Among authors: gibson ge. J Neurosci Res. 2003 Oct 15;74(2):309-17. doi: 10.1002/jnr.10756. J Neurosci Res. 2003. PMID: 14515360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters